Shandong Xinhua Pharmaceutical Co Ltd (000756) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of CN¥56.11 Million could theoretically repay 0% of its total liabilities (CN¥3.22 Billion) in one year. See 000756 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Co Ltd across 10 annual periods. Also explore 000756 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 000756 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥367.61 Million | CN¥3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | CN¥265.28 Million | CN¥3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | CN¥758.24 Million | CN¥3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | CN¥259.12 Million | CN¥3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | CN¥420.19 Million | CN¥3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | CN¥348.27 Million | CN¥3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | CN¥323.91 Million | CN¥3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | CN¥389.97 Million | CN¥2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | CN¥439.35 Million | CN¥2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | CN¥348.64 Million | CN¥2.51 Billion | — |